+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Piroxicam Oral Tablets Market - Global Forecast 2025-2030- Product Image
Piroxicam Oral Tablets Market - Global Forecast 2025-2030- Product Image
Sale

Piroxicam Oral Tablets Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6145825
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Piroxicam oral tablets continue to play a central role in musculoskeletal pain management strategies, supported by evolving formulation science and digital adoption. Amid an increasingly dynamic regulatory and commercial landscape, industry decision-makers require clarity on new challenges and opportunities shaping this well-established NSAID segment.

Market Snapshot of Piroxicam Oral Tablets

The piroxicam oral tablet market remains resilient, reflecting stable clinical demand across acute and chronic indications. Adoption is driven by a balance of efficacy and tolerability, reinforced by both immediate and extended release variants. Growth is paced by advancements in drug delivery, augmented digital distribution networks, and shifting regional procurement approaches. The sector's trajectory is further influenced by regulatory recalibrations, with notable attention on evolving approval pathways and the integration of real-world evidence into market access strategies.

Scope & Segmentation of the Piroxicam Oral Tablet Market

This report provides a comprehensive evaluation by segment, technology, and geographical focus, equipping senior executives with a clear framework for strategy development.

  • Release Types: Extended Release; Immediate Release
  • Distribution Channels: E-Commerce (Mobile Pharmacies, Web Pharmacies); Hospital Pharmacies (Private, Public); Retail Pharmacies (Chain, Independent)
  • Dosage Strengths: 10 mg; 20 mg
  • End Users: Clinics; Hospitals; Homecare Settings
  • Therapeutic Indications: Acute Pain; Dysmenorrhea; Osteoarthritis; Rheumatoid Arthritis
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina, with detailed coverage in California, Texas, New York, Florida, Illinois, Pennsylvania, and Ohio), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Technological Advancements: Advanced drug delivery systems; Real-world evidence studies; Digital pharmacies; Remote patient monitoring; Enhanced supply chain technologies
  • Company Analysis: Teva Pharmaceutical Industries Ltd.; Sandoz International GmbH; Viatris Inc.; Dr. Reddy’s Laboratories Ltd.; Sun Pharmaceutical Industries Ltd.; Cipla Ltd.; Aurobindo Pharma Ltd.; Lupin Ltd.; Cadila Healthcare Ltd.; Glenmark Pharmaceuticals Ltd.

Key Takeaways for Leaders in the Piroxicam Oral Tablet Sector

  • Extended release and immediate release formulations support clinical flexibility, matching treatment protocols for distinct pain profiles and patient adherence needs.
  • Digital transformation in distribution channels offers wider reach, streamlines patient support, and enhances access beyond traditional pharmacy settings.
  • Regional dynamics emphasize the significance of localized strategies, as procurement patterns and regulatory environments vary across mature and emerging markets.
  • Strategic partnerships, including co-marketing and manufacturing agreements, enable agile responses to changing commercial and supply landscapes.
  • Payer engagement benefits from real-world evidence that demonstrates patient outcomes and supports value-based contracting models.
  • Investment in advanced drug delivery and adaptive clinical trial methodologies can strengthen competitive positioning and brand differentiation.

Tariff Impact: United States 2025 Tariffs

US tariffs introduced in 2025 have introduced operational complexity for piroxicam oral tablet manufacturers, particularly those sourcing APIs internationally. Companies have responded with supplier negotiations, nearshoring initiatives, strategic partnerships with regional manufacturers, and revised inventory practices. These adaptations aim to maintain cost control, ensure continuity, and uphold competitive pricing for stakeholders and patients.

Methodology & Data Sources

This report integrates a multi-tiered research methodology, combining peer-reviewed literature review, regulatory and industry data, and interviews with key opinion leaders across the clinical, supply chain, and technology domains. Expert validation ensures reliability and actionable insight.

Piroxicam Oral Tablets: Why This Report Matters

  • Enables executive leadership to identify high-impact areas for portfolio enhancement, investment, or partnership, aligned with shifting technological and geographic trends.
  • Equips commercial teams with segmentation analysis and competitive intelligence to inform market entry or expansion strategies.
  • Guides supply chain, regulatory, and digital transformation decisions to support long-term performance and mitigate external disruptions.

Conclusion

The piroxicam oral tablet market is shaped by ongoing therapeutic innovation, digital distribution, and regional variability. Senior decision-makers equipped with this report’s insights can drive sustainable growth and operational excellence amid evolving market realities.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of novel controlled-release piroxicam formulations to improve patient adherence and reduce gastrointestinal side effects
5.2. Intensifying price competition from generic manufacturers driving margins down in the piroxicam oral tablets market
5.3. Emergence of bioequivalent piroxicam products raising regulatory and quality scrutiny across multiple regions
5.4. Growing emphasis on pharmacovigilance and safety warnings following NSAID-related cardiovascular risk concerns
5.5. Expansion of piroxicam oral tablet demand in emerging Asian and Latin American markets due to rising osteoarthritis prevalence
5.6. Integration of digital patient monitoring and telemedicine platforms to enhance treatment adherence among piroxicam users
5.7. Supply chain disruptions and active pharmaceutical ingredient shortages impacting piroxicam production timelines globally
5.8. Heightened regulatory approvals for novel piroxicam extended-release tablets targeting chronic pain management
5.9. Strategic alliances between local pharmaceutical companies and multinational firms to co-market piroxicam brands in high-growth markets
5.10. Advances in bioavailability enhancement techniques such as nanotechnology and lipid-based formulations for piroxicam tablets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Piroxicam Oral Tablets Market, by Release Type
8.1. Introduction
8.2. Extended Release
8.3. Immediate Release
9. Piroxicam Oral Tablets Market, by Distribution Channel
9.1. Introduction
9.2. E-Commerce
9.2.1. Mobile Pharmacies
9.2.2. Web Pharmacies
9.3. Hospital Pharmacies
9.3.1. Private Hospitals
9.3.2. Public Hospitals
9.4. Retail Pharmacies
9.4.1. Chain Pharmacies
9.4.2. Independent Pharmacies
10. Piroxicam Oral Tablets Market, by Dosage Strength
10.1. Introduction
10.2. 10 Mg
10.3. 20 Mg
11. Piroxicam Oral Tablets Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Homecare Settings
11.4. Hospitals
12. Piroxicam Oral Tablets Market, by Indication
12.1. Introduction
12.2. Acute Pain
12.3. Dysmenorrhea
12.4. Osteoarthritis
12.5. Rheumatoid Arthritis
13. Americas Piroxicam Oral Tablets Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Piroxicam Oral Tablets Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Piroxicam Oral Tablets Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Sandoz International GmbH
16.3.3. Viatris Inc.
16.3.4. Dr. Reddy's Laboratories Ltd.
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Cipla Ltd.
16.3.7. Aurobindo Pharma Ltd.
16.3.8. Lupin Ltd.
16.3.9. Cadila Healthcare Ltd.
16.3.10. Glenmark Pharmaceuticals Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PIROXICAM ORAL TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PIROXICAM ORAL TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PIROXICAM ORAL TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PIROXICAM ORAL TABLETS MARKET: RESEARCHAI
FIGURE 26. PIROXICAM ORAL TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 27. PIROXICAM ORAL TABLETS MARKET: RESEARCHCONTACTS
FIGURE 28. PIROXICAM ORAL TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PIROXICAM ORAL TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY MOBILE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY MOBILE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY WEB PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY WEB PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY 10 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY 10 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY 20 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY 20 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY DYSMENORRHEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY DYSMENORRHEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PIROXICAM ORAL TABLETS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES PIROXICAM ORAL TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 106. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 107. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 108. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 109. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 110. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 111. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 112. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 113. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 124. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 125. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 128. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 129. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 208. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 209. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 210. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 211. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. GERMANY PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 216. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 217. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 220. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 221. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 222. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 223. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 224. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 225. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 226. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 227. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. FRANCE PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 248. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 249. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 252. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 253. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 254. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 255. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 256. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 257. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 258. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 259. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. ITALY PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 268. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 269. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 270. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 271. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 272. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 273. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 274. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 275. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. SPAIN PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY RELEASE TYPE, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA PIROXICAM ORAL TABLETS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Piroxicam Oral Tablets market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Ltd.
  • Aurobindo Pharma Ltd.
  • Lupin Ltd.
  • Cadila Healthcare Ltd.
  • Glenmark Pharmaceuticals Ltd.

Related Topics

Related Reports

Piroxicam Patch Market - Global Forecast to 2030 - Product Image

Piroxicam Patch Market - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Piroxicam Patches Market - Global Forecast 2025-2030 - Product Image

Piroxicam Patches Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Piroxicam (CAS 36322-90-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Piroxicam (CAS 36322-90-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (NSAIDs, Corticosteroids), By Anatomy (Hip Osteoarthritis), By Route Of Administration (Topical Route, Oral Route), By Sales Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (NSAIDs, Corticosteroids), By Anatomy (Hip Osteoarthritis), By Route Of Administration (Topical Route, Oral Route), By Sales Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Systemic Lupus Erythematosus Drugs Market 2025-2033 - Product Image

Systemic Lupus Erythematosus Drugs Market 2025-2033

  • Report
  • 144 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.